Clinical Trials
Currently Enrolling Clinical Trials:
|
Study Drug (Sponsor) |
Condition |
Key Inclusion Criteria |
|
Telitacecept (RemeGen) |
IgA Nephropathy |
|
|
IGNAZ: Felzartamab (MorphoSys) |
IgA Nephropathy |
|
|
ALIGN: Atrasentan (Chinook) |
IgA Nephropathy |
|
Please contact research coordinator Divya Seth [email protected] if you or your patient is interested in participating in any of the above studies.
UPCOMING CLINICAL TRIALS:
|
Study Drug (Sponsor) |
Condition |
Key Inclusion Criteria |
|
REBOOT: Belimumab with Rituximab (ITN) |
Primary Membranous Nephropathy |
|
|
VB119 (ValenzaBio) |
Primary Membranous Nephropathy |
|
|
VB119 (ValenzaBio) |
Focal Segmental Glomerulosclerosis (FSGS) and Minimal Change Disease (MCD) |
|
|
VIS649 (Otsuka) |
IgA Nephropathy |
|
Please contact research coordinator Divya Seth [email protected] if you or your patient is interested in participating in any of the above studies.
Cohorts & Collaborations
UCSF Autoimmunoprofiler: A translational platform to enhance treatment efficacy, develop precision medicines and understand the immunological basis for disease. We will be prospectively collecting kidney tissue samples from patients with autoimmune diseases such as lupus, to help with better understanding of underlying mechanisms of autoimmune diseases, identification of the relationship between tissue and peripheral compartment, and the identification of novel pathways and targets for future drug discovery and development.
CKDopps: The Chronic Kidney Disease Outcomes and Practice Patterns Study. We are a recruitment and collaborating site for this multinational CKD cohort study
GlomCon: The Glomerular Disease Glomerular Disease Study & Trial Consortium. We are involved in building a clinical data registry and in the educational mission of GlomCon.
ICPi-AKI Consortium based at the Brigham & Women's Hospital/Harvard Medical School. We are actively collaborating with this multinational consortium of investigators studying the renal effects of immune checkpoint inhibitors among patients with cancer.
International Kidney Disorder Registry (K-REG) based at the University of Pennsylvania Glomerular Disease Center. We are a contributing site for this international registry with a focus on rare kidney disorders.
.